CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Total Liabilities (Quarterly): 142.43M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 142.43M |
| September 30, 2023 | 124.86M |
| June 30, 2023 | 118.24M |
| March 31, 2023 | 141.13M |
| December 31, 2022 | 105.70M |
| September 30, 2022 | 99.07M |
| June 30, 2022 | 95.27M |
| March 31, 2022 | 93.26M |
| December 31, 2021 | 69.38M |
| September 30, 2021 | 35.84M |
| June 30, 2021 | 9.947M |
| March 31, 2021 | 9.036M |
| December 31, 2020 | 11.12M |
| September 30, 2020 | 11.85M |
| June 30, 2020 | 10.99M |
| March 31, 2020 | 13.55M |
| December 31, 2019 | 19.38M |
| September 30, 2019 | 19.21M |
| June 30, 2019 | 17.38M |
| March 31, 2019 | 16.53M |
| December 31, 2018 | 16.33M |
| Date | Value |
|---|---|
| September 30, 2018 | 15.58M |
| June 30, 2018 | 18.96M |
| March 31, 2018 | 20.06M |
| December 31, 2017 | 19.30M |
| September 30, 2017 | 17.84M |
| June 30, 2017 | 16.59M |
| March 31, 2017 | 16.15M |
| December 31, 2016 | 15.42M |
| September 30, 2016 | 14.57M |
| June 30, 2016 | 15.05M |
| March 31, 2016 | 14.92M |
| December 31, 2015 | 14.96M |
| September 30, 2015 | 15.37M |
| June 30, 2015 | 10.99M |
| March 31, 2015 | 16.46M |
| December 31, 2014 | 23.62M |
| September 30, 2014 | 18.52M |
| June 30, 2014 | 17.56M |
| March 31, 2014 | 19.82M |
| December 31, 2013 | 13.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.036M
Minimum
Mar 2021
142.43M
Maximum
Dec 2023
60.40M
Average
35.84M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences Inc | 38.84B |
| Assure Holdings Corp | 22.85M |
| Societal CDMO Inc (DELISTED) | 94.81M |
| AN2 Therapeutics Inc | 14.04M |
| Madrigal Pharmaceuticals Inc | 235.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 434.69M |
| Shareholders Equity (Quarterly) | 292.26M |
| Debt to Equity Ratio | 0.3735 |
| Current Ratio | 10.96 |
| Net Debt Paydown Yield | -0.17% |